Oncternal Therapeutics Inc (ONCT) Stock Balance Sheet
NASDAQ:ONCT - Nasdaq - US68236P2065 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 13.08M | 6.70M | 37.14M | 90.77M | 116.74M | |||
| Marketable Securities | 1.50M | 27.56M | 26.58M | N/A | N/A | |||
| Receivables | 344.00K | 632.00K | 178.00K | N/A | N/A | |||
| Other Current Assets | 525.00K | 1.17M | 3.39M | 2.09M | 1.27M | |||
| Total Current Assets | 15.45M | 36.06M | 67.29M | 92.85M | 118.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 154.00K | 258.00K | 87.00K | 75.00K | 40.00K | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 0.00 | 412.00K | 1.27M | 657.00K | 766.00K | |||
| Total Non-Current Assets | 154.00K | 670.00K | 1.36M | 732.00K | 806.00K | |||
| TOTAL ASSETS | 15.60M | 36.73M | 68.65M | 93.58M | 118.81M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 5.25M | 4.05M | 4.76M | 3.51M | 3.08M | |||
| Accounts Payable | 1.20M | 1.15M | 2.92M | 1.96M | 1.14M | |||
| Other Current Liabilities | N/A | N/A | N/A | 0.00 | 1.63M | |||
| Total Current Liabilities | 6.45M | 5.20M | 7.68M | 5.46M | 5.86M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 1.48M | N/A | N/A | 0.00 | |||
| Total Non-Current Liabilities | 0.00 | 1.48M | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 6.45M | 6.68M | 7.68M | 5.46M | 5.86M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -223.19M | -197.78M | -158.30M | -114.13M | -82.80M | |||
| Additional Paid In Capital | 232.33M | 227.82M | 219.20M | 202.20M | 195.70M | |||
| Common Shares | 3.00K | 3.00K | 57.00K | 49.00K | 49.00K | |||
| Other Shareholders' Equity | 1.00K | 3.00K | 9.00K | N/A | N/A | |||
| Shares Outstanding | 2.96M | 2.95M | 2.87M | 2.47M | 2.44M | |||
| Tangible Book Value per Share | 3.09 | 10.19 | 21.22 | 35.66 | 46.29 | |||
| Total Shareholders' Equity | 9.15M | 30.05M | 60.97M | 88.12M | 112.95M | |||
| TOTAL LIABILITIES AND EQUITY | 15.60M | 36.73M | 68.65M | 93.58M | 118.81M | |||
| Statistics | ||||||||
| Current Ratio | 2.39 | 6.94 | 8.76 | 16.99 | 20.14 | |||
| Return On Assets (ROA) | -221.62% | -107.49% | -64.34% | -33.48% | -14.50% | |||
| Return On Equity (ROE) | -377.95% | -131.37% | -72.45% | -35.56% | -15.25% | |||
All data in USD , ROIC based on taxRate of 0.21